What Comes Next Could Be a Once-in-a-Lifetime Opportunity

A wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.

Click here now to watch the full briefing and discover the steps to take today.

Fred Hite Biography and Net Worth

CFO of OrthoPediatrics

Fred Hite is currently OrthoPediatrics’ Chief Financial Officer & Chief Operating Officer, joining the Company in February 2015. Mr. Hite also serves as a Director on the Board for OrthoPediatrics. Prior to joining OrthoPediatrics, Mr. Hite spent over ten years as the CFO and Investor Relations Officer of Symmetry Medical, a NYSE listed publicly traded company. During his time at Symmetry Medical, the company completed an Initial Public Offering (IPO), a secondary offering and nine acquisitions. Prior to Symmetry Medical, Mr. Hite spent thirteen years with General Electric in a variety of financial positions and areas including commercial, manufacturing, sourcing, and services. Hite earned his Bachelor of Science degree in Finance from Indiana University. He has been actively involved with Junior Achievement for over 20 years and spent over 10 years as the local President of the Board of Directors for Junior Achievement.

What is Fred Hite's net worth?: The estimated net worth of Fred Hite is at least $2.49 million as of March 11th, 2024. Mr. Hite owns 94,072 shares of OrthoPediatrics stock worth more than $2,489,136 as of November 22nd. This net worth estimate does not reflect any other assets that Mr. Hite may own. Additionally, Mr. Hite receives a salary of $578,750.00 as CFO at OrthoPediatrics. Learn More about Fred Hite's net worth.
How old is Fred Hite?: Mr. Hite is currently 56 years old. There are 6 older executives and no younger executives at OrthoPediatrics. The oldest executive at OrthoPediatrics is Mr. Mark C. Throdahl, Executive Chairman, who is 73 years old. Learn More on Fred Hite's age.
What is Fred Hite's salary?: As the CFO of OrthoPediatrics Corp., Mr. Hite earns $578,750.00 per year. The highest earning executive at OrthoPediatrics is Mr. David R. Bailey, President, CEO & Director, who commands a salary of $588,470.00 per year. Learn More on Fred Hite's salary.
How do I contact Fred Hite?: The corporate mailing address for Mr. Hite and other OrthoPediatrics executives is 2850 Frontier Drive, Warsaw IN, 46582. OrthoPediatrics can also be reached via phone at (574) 268-6379 and via email at [email protected]. Learn More on Fred Hite's contact information.
Has Fred Hite been buying or selling shares of OrthoPediatrics?: Fred Hite has not been actively trading shares of OrthoPediatrics within the last three months. Most recently, Fred Hite sold 3,195 shares of the business's stock in a transaction on Monday, March 11th. The shares were sold at an average price of $27.59, for a transaction totalling $88,150.05. Following the completion of the sale, the chief financial officer now directly owns 94,072 shares of the company's stock, valued at $2,595,446.48. Learn More on Fred Hite's trading history.
Who are OrthoPediatrics' active insiders?: OrthoPediatrics' insider roster includes Bernei Berry, III (Director), Stephen Burns (Director), Fred Hite (CFO), Marie Infante (Director), Gregory Odle (EVP), Jennifer Pritzker (Major Shareholder), Terry Schlotterback (Director), and Mark Throdahl (CEO). Learn More on OrthoPediatrics' active insiders.
Are insiders buying or selling shares of OrthoPediatrics?: In the last twelve months, insiders at the sold shares 7 times. They sold a total of 27,253 shares worth more than $770,374.68. The most recent insider tranaction occured on August, 21st when General Counsel Daniel J Gerritzen sold 10,000 shares worth more than $293,000.00. Insiders at OrthoPediatrics own 31.8% of the company. Learn More about insider trades at OrthoPediatrics.
Information on this page was last updated on 8/21/2024.

Fred Hite Insider Trading History at OrthoPediatrics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/11/2024	Sell	3,195	$27.59	$88,150.05	94,072
6/26/2023	Sell	4,356	$43.69	$190,313.64	97,267
3/6/2023	Sell	4,099	$43.77	$179,413.23	71,623
3/2/2022	Sell	4,919	$57.48	$282,744.12
9/2/2021	Sell	5,000	$71.50	$357,500.00
3/1/2021	Sell	4,310	$55.87	$240,799.70	63,686
4/13/2018	Sell	29,471	$17.92	$528,120.32

Fred Hite Buying and Selling Activity at OrthoPediatrics

OrthoPediatrics Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $26.46

$25.38

$26.73

50 Day Range

MA: $26.67

$22.69

$32.28

2 Week Range

Now: $26.46

$22.41

$36.23

Volume

141,733 shs

Average Volume

169,186 shs

Market Capitalization

$640.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

What Comes Next Could Be a Once-in-a-Lifetime Opportunity

From InvestorPlace | Ad

Click here now to watch the full briefing and discover the steps to take today.

Fred Hite Biography and Net Worth

What is Fred Hite's net worth?

How old is Fred Hite?

What is Fred Hite's salary?

How do I contact Fred Hite?

Has Fred Hite been buying or selling shares of OrthoPediatrics?

Who are OrthoPediatrics' active insiders?

Are insiders buying or selling shares of OrthoPediatrics?